Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 2 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Completed Country / region: Brazil Clear all

222 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20035
20043
20053
200621
20079
200814
200919
201026
201110
201211
201314
201414
20155
201613
201714
20185
20197
20207
20213
20226
20237
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed222

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company30
Novo Nordisk A/S30
Sanofi17
AstraZeneca13
Takeda11
Hospital de Clinicas de Porto Alegre10
Hoffmann-La Roche9
University of Campinas, Brazil9
Boehringer Ingelheim8
University of Sao Paulo8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2222
Diabetes Mellitus71
Glucose Metabolism Disorders13
Insulin Resistance13
Obesity12
Dyslipidemias10
Renal Insufficiency, Chronic8
Hyperglycemia7
Metabolic Diseases7
Overweight6

Trials

Showing 1 to 25 of 222. Each trial links to its page on Pharma Observatory.

122 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.